In this post we overview Parkinson’s Disease ICD 10 Codes

2024 ICD-10-CM Diagnosis Code G20

Parkinson’s disease

G20 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.

ICD-10-CM G20 is a new 2024 ICD-10-CM code that became effective on October 1, 2023.

This is the American ICD-10-CM version of G20 – other international versions of ICD-10 G20 may differ.

Applicable To:

Hemiparkinsonism
Idiopathic Parkinsonism or Parkinson’s disease
Paralysis agitans
Primary Parkinsonism or Parkinson’s disease
Use Additional

code, if applicable, to identify:

Dementia with anxiety (F02.84, F02.A4, F02.B4, F02.C4)
Dementia with behavioral disturbance (F02.81-, F02.A1-, F02.B1-, F02.C1-)
Dementia with mood disturbance (F02.83, F02.A3, F02.B3, F02.C3)
Dementia with psychotic disturbance (F02.82, F02.A2, F02.B2, F02.C2)
Dementia without behavioral disturbance (F02.80, F02.A0, F02.B0, F02.C0)
mild neurocognitive disorder due to known physiological condition (F06.7-)
The following code(s) above G20 contain annotation back-references that may be applicable to G20:

G00-G99 – Diseases of the nervous system

Approximate Synonyms

Dementia associated with Parkinson’s disease
Dementia in Parkinson’s disease
Parkinsonism
Parkinsons disease
Restrictive lung disease due to Parkinson’s disease
Restrictive lung mechanics due to Parkinson’s disease
Clinical Information

A disease characterized as a progressive motor disability manifested by tremors, shaking, muscular rigidity, and lack of postural reflexes.
A progressive degenerative disorder of the central nervous system characterized by loss of dopamine producing neurons in the substantia nigra and the presence of lewy bodies in the substantia nigra and locus coeruleus. Signs and symptoms include tremor which is most pronounced during rest, muscle rigidity, slowing of the voluntary movements, a tendency to fall back, and a mask-like facial expression.
A progressive disorder of the nervous system marked by muscle tremors, muscle rigidity, decreased mobility, stooped posture, slow voluntary movements, and a mask-like facial expression.
A progressive, degenerative neurologic disease characterized by a tremor that is maximal at rest, retropulsion (i.e. A tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. Lewy bodies are present in the substantia nigra and locus coeruleus but may also be found in a related condition (lewy body disease, diffuse) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
Parkinson’s disease is a disorder that affects nerve cells, or neurons, in a part of the brain that controls muscle movement. In Parkinson’s, neurons that make a chemical called dopamine die or do not work properly. Dopamine normally sends signals that help coordinate your movements. No one knows what damages these cells. Symptoms of Parkinson’s disease may include:
trembling of hands, arms, legs, jaw and face
stiffness of the arms, legs and trunk
slowness of movement
poor balance and coordination
as symptoms get worse, people with the disease may have trouble walking, talking or doing simple tasks. They may also have problems such as depression, sleep problems or trouble chewing, swallowing or speaking. Parkinson’s usually begins around age 60, but it can start earlier. It is more common in men than in women. There is no cure for parkinson’s disease. A variety of medicines sometimes help symptoms dramatically.

Progressive, degenerative disorder of the nervous system characterized by tremors, rigidity, bradykinesia, postural instability, and gait abnormalities; caused by a loss of neurons and a decrease of dopamine in the basal ganglia.
Code History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
2017 (effective 10/1/2016): No change
2018 (effective 10/1/2017): No change
2019 (effective 10/1/2018): No change
2020 (effective 10/1/2019): No change
2021 (effective 10/1/2020): No change
2022 (effective 10/1/2021): No change
2023 (effective 10/1/2022): No change
2024 (effective 10/1/2023): Deleted code
2024 (effective 10/1/2023): New code
Code annotations containing back-references to G20:

Code First: F02, R47.82, F06.7
If you would like to learn more about Parkingson’s ICD 10 Codes, please call us at 610-428-9034 or fill out our Contact Form.

In this post, we detail the Cervical Cancer ICD 10 Codes.

ICD-10-CM Codes › C00-D49 › C51-C58 › Malignant neoplasm of cervix uteri C53

Malignant neoplasm of cervix uteri C53-

Type 1 Excludes carcinoma in situ of cervix uteri (D06.-)

Clinical Information

• Primary or metastatic malignant neoplasm involving the cervix.
• The cervix is the lower part of the uterus, the place where a baby grows during pregnancy. Cervical cancer is caused by a virus called HPV. The virus spreads through sexual contact. Most women’s bodies are able to fight HPV infection. But sometimes the virus leads to cancer. You’re at higher risk if you smoke, have many children, use birth control pills for a long time, or have HIV infection. Cervical cancer may not cause any symptoms at first. Later, you may have pelvic pain or bleeding from the vagina. It usually takes several years for normal cells in the cervix to turn into cancer cells. Your health care provider can find abnormal cells by doing a pap test – examining cells from the cervix under a microscope. If there are abnormal cells, you will need a biopsy. By getting regular pap tests and pelvic exams you can find and treat any problems before they turn into cancer. Treatment may include surgery, radiation therapy, chemotherapy, or a combination. The choice of treatment depends on the size of the tumor, whether the cancer has spread and whether you would like to become pregnant someday. Vaccines can protect against several types of HPV, including some that can cause cancer. NIH: national cancer institute

Codes

C53 Malignant neoplasm of cervix uteri

C53.0 Malignant neoplasm of endocervix

C53.1 Malignant neoplasm of exocervix

C53.8 Malignant neoplasm of overlapping sites of cervix uteri

C53.9 Malignant neoplasm of cervix uteri, unspecified

To learn more about Cervical Cancer ICD 10 Codes, please call us at 610-428-9034 or fill out our Contact Form.

In this post, we detail the Glaucoma ICD 10 Codes.

ICD-10-CM Codes › H00-H59 › H40-H42 › Glaucoma H40

Glaucoma H40-

Type 1 Excludes

• Absolute glaucoma (H44.51-)
• Congenital glaucoma (Q15.0)
• Traumatic glaucoma due to birth injury (P15.3)

Clinical Information

• A condition in which there is a build-up of fluid in the eye, which presses on the retina and the optic nerve. The retina is the layer of nerve tissue inside the eye that senses light and sends images along the optic nerve to the brain. Glaucoma can damage the optic nerve and cause loss of vision or blindness.
• A disorder characterized by an increase in pressure in the eyeball due to obstruction of the aqueous humor outflow.
• An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (dictionary of visual science, 4th ed)
• Glaucoma damages the eye’s optic nerve. It is a leading cause of blindness in the United States. It usually happens when the fluid pressure inside the eyes slowly rises, damaging the optic nerve. Often there are no symptoms at first, but a comprehensive eye exam can detect it. People at risk should get eye exams at least every two years. They include:
• African Americans over age 40
• people over age 60, especially Mexican Americans
• people with a family history of glaucoma
• Early treatment can help protect your eyes against vision loss. Treatments usually include prescription eyedrops and/or surgery. nih: national eye institute
• Group of diseases characterized by increased intraocular pressure resulting in damage to the optic nerve and retinal nerve fibers.
• Increased pressure in the eyeball due to obstruction of the outflow of aqueous humor.

Codes

H40 Glaucoma

H40.0 Glaucoma suspect

H40.00 Preglaucoma, unspecified

H40.001 …… right eye

H40.002 …… left eye

H40.003 …… bilateral

H40.009 …… unspecified eye

H40.01 Open angle with borderline findings, low risk

H40.011 …… right eye

H40.012 …… left eye

H40.013 …… bilateral

H40.019 …… unspecified eye

H40.02 Open angle with borderline findings, high risk

H40.021 …… right eye

H40.022 …… left eye

H40.023 …… bilateral

H40.029 …… unspecified eye

H40.03 Anatomical narrow angle

H40.031 …… right eye

H40.032 …… left eye

H40.033 …… bilateral

H40.039 …… unspecified eye

H40.04 Steroid responder

H40.041 …… right eye

H40.042 …… left eye

H40.043 …… bilateral

H40.049 …… unspecified eye

H40.05 Ocular hypertension

H40.051 …… right eye

H40.052 …… left eye

H40.053 …… bilateral

H40.059 …… unspecified eye

H40.06 Primary angle closure without glaucoma damage

H40.061 …… right eye

H40.062 …… left eye

H40.063 …… bilateral

H40.069 …… unspecified eye

H40.1 Open-angle glaucoma

H40.10 Unspecified open-angle glaucoma

H40.10X0 …… stage unspecified

H40.10X1 …… mild stage

H40.10X2 …… moderate stage

H40.10X3 …… severe stage

H40.10X4 …… indeterminate stage

H40.11 Primary open-angle glaucoma

H40.111 Primary open-angle glaucoma, right eye

H40.1110 …… stage unspecified

H40.1111 …… mild stage

H40.1112 …… moderate stage

H40.1113 …… severe stage

H40.1114 …… indeterminate stage

H40.112 Primary open-angle glaucoma, left eye

H40.1120 …… stage unspecified

H40.1121 …… mild stage

H40.1122 …… moderate stage

H40.1123 …… severe stage

H40.1124 …… indeterminate stage

H40.113 Primary open-angle glaucoma, bilateral

H40.1130 …… stage unspecified

H40.1131 …… mild stage

H40.1132 …… moderate stage

H40.1133 …… severe stage

H40.1134 …… indeterminate stage

H40.119 Primary open-angle glaucoma, unspecified eye

H40.1190 …… stage unspecified

H40.1191 …… mild stage

H40.1192 …… moderate stage

H40.1193 …… severe stage

H40.1194 …… indeterminate stage

H40.12 Low-tension glaucoma

H40.121 Low-tension glaucoma, right eye

H40.1210 …… stage unspecified

H40.1211 …… mild stage

H40.1212 …… moderate stage

H40.1213 …… severe stage

H40.1214 …… indeterminate stage

H40.122 Low-tension glaucoma, left eye

H40.1220 …… stage unspecified

H40.1221 …… mild stage

H40.1222 …… moderate stage

H40.1223 …… severe stage

H40.1224 …… indeterminate stage

H40.123 Low-tension glaucoma, bilateral

H40.1230 …… stage unspecified

H40.1231 …… mild stage

H40.1232 …… moderate stage

H40.1233 …… severe stage

H40.1234 …… indeterminate stage

H40.129 Low-tension glaucoma, unspecified eye

H40.1290 …… stage unspecified

H40.1291 …… mild stage

H40.1292 …… moderate stage

H40.1293 …… severe stage

H40.1294 …… indeterminate stage

H40.13 Pigmentary glaucoma

H40.131 Pigmentary glaucoma, right eye

H40.1310 …… stage unspecified

H40.1311 …… mild stage

H40.1312 …… moderate stage

H40.1313 …… severe stage

H40.1314 …… indeterminate stage

H40.132 Pigmentary glaucoma, left eye

H40.1320 …… stage unspecified

H40.1321 …… mild stage

H40.1322 …… moderate stage

H40.1323 …… severe stage

H40.1324 …… indeterminate stage

H40.133 Pigmentary glaucoma, bilateral

H40.1330 …… stage unspecified

H40.1331 …… mild stage

H40.1332 …… moderate stage

H40.1333 …… severe stage

H40.1334 …… indeterminate stage

H40.139 Pigmentary glaucoma, unspecified eye

H40.1390 …… stage unspecified

H40.1391 …… mild stage

H40.1392 …… moderate stage

H40.1393 …… severe stage

H40.1394 …… indeterminate stage

H40.14 Capsular glaucoma with pseudoexfoliation of lens

H40.141 Capsular glaucoma with pseudoexfoliation of lens, right eye

H40.1410 …… stage unspecified

H40.1411 …… mild stage

H40.1412 …… moderate stage

H40.1413 …… severe stage

H40.1414 …… indeterminate stage

H40.142 Capsular glaucoma with pseudoexfoliation of lens, left eye

H40.1420 …… stage unspecified

H40.1421 …… mild stage

H40.1422 …… moderate stage

H40.1423 …… severe stage

H40.1424 …… indeterminate stage

H40.143 Capsular glaucoma with pseudoexfoliation of lens, bilateral

H40.1430 …… stage unspecified

H40.1431 …… mild stage

H40.1432 …… moderate stage

H40.1433 …… severe stage

H40.1434 …… indeterminate stage

H40.149 Capsular glaucoma with pseudoexfoliation of lens, unspecified eye

H40.1490 …… stage unspecified

H40.1491 …… mild stage

H40.1492 …… moderate stage

H40.1493 …… severe stage

H40.1494 …… indeterminate stage

H40.15 Residual stage of open-angle glaucoma

H40.151 …… right eye

H40.152 …… left eye

H40.153 …… bilateral

H40.159 …… unspecified eye

H40.2 Primary angle-closure glaucoma

H40.20 Unspecified primary angle-closure glaucoma

H40.20X0 …… stage unspecified

H40.20X1 …… mild stage

H40.20X2 …… moderate stage

H40.20X3 …… severe stage

H40.20X4 …… indeterminate stage

H40.21 Acute angle-closure glaucoma

H40.211 …… right eye

H40.212 …… left eye

H40.213 …… bilateral

H40.219 …… unspecified eye

H40.22 Chronic angle-closure glaucoma

H40.221 Chronic angle-closure glaucoma, right eye

H40.2210 …… stage unspecified

H40.2211 …… mild stage

H40.2212 …… moderate stage

H40.2213 …… severe stage

H40.2214 …… indeterminate stage

H40.222 Chronic angle-closure glaucoma, left eye

H40.2220 …… stage unspecified

H40.2221 …… mild stage

H40.2222 …… moderate stage

H40.2223 …… severe stage

H40.2224 …… indeterminate stage

H40.223 Chronic angle-closure glaucoma, bilateral

H40.2230 …… stage unspecified

H40.2231 …… mild stage

H40.2232 …… moderate stage

H40.2233 …… severe stage

H40.2234 …… indeterminate stage

H40.229 Chronic angle-closure glaucoma, unspecified eye

H40.2290 …… stage unspecified

H40.2291 …… mild stage

H40.2292 …… moderate stage

H40.2293 …… severe stage

H40.2294 …… indeterminate stage

H40.23 Intermittent angle-closure glaucoma

H40.231 …… right eye

H40.232 …… left eye

H40.233 …… bilateral

H40.239 …… unspecified eye

H40.24 Residual stage of angle-closure glaucoma

H40.241 …… right eye

H40.242 …… left eye

H40.243 …… bilateral

H40.249 …… unspecified eye

H40.3 Glaucoma secondary to eye trauma

H40.30 Glaucoma secondary to eye trauma, unspecified eye

H40.30X0 …… stage unspecified

H40.30X1 …… mild stage

H40.30X2 …… moderate stage

H40.30X3 …… severe stage

H40.30X4 …… indeterminate stage

H40.31 Glaucoma secondary to eye trauma, right eye

H40.31X0 …… stage unspecified

H40.31X1 …… mild stage

H40.31X2 …… moderate stage

H40.31X3 …… severe stage

H40.31X4 …… indeterminate stage

H40.32 Glaucoma secondary to eye trauma, left eye

H40.32X0 …… stage unspecified

H40.32X1 …… mild stage

H40.32X2 …… moderate stage

H40.32X3 …… severe stage

H40.32X4 …… indeterminate stage

H40.33 Glaucoma secondary to eye trauma, bilateral

H40.33X0 …… stage unspecified

H40.33X1 …… mild stage

H40.33X2 …… moderate stage

H40.33X3 …… severe stage

H40.33X4 …… indeterminate stage

H40.4 Glaucoma secondary to eye inflammation

H40.40 Glaucoma secondary to eye inflammation, unspecified eye

H40.40X0 …… stage unspecified

H40.40X1 …… mild stage

H40.40X2 …… moderate stage

H40.40X3 …… severe stage

H40.40X4 …… indeterminate stage

H40.41 Glaucoma secondary to eye inflammation, right eye

H40.41X0 …… stage unspecified

H40.41X1 …… mild stage

H40.41X2 …… moderate stage

H40.41X3 …… severe stage

H40.41X4 …… indeterminate stage

H40.42 Glaucoma secondary to eye inflammation, left eye

H40.42X0 …… stage unspecified

H40.42X1 …… mild stage

H40.42X2 …… moderate stage

H40.42X3 …… severe stage

H40.42X4 …… indeterminate stage

H40.43 Glaucoma secondary to eye inflammation, bilateral

H40.43X0 …… stage unspecified

H40.43X1 …… mild stage

H40.43X2 …… moderate stage

H40.43X3 …… severe stage

H40.43X4 …… indeterminate stage

H40.5 Glaucoma secondary to other eye disorders

H40.50 Glaucoma secondary to other eye disorders, unspecified eye

H40.50X0 …… stage unspecified

H40.50X1 …… mild stage

H40.50X2 …… moderate stage

H40.50X3 …… severe stage

H40.50X4 …… indeterminate stage

H40.51 Glaucoma secondary to other eye disorders, right eye

H40.51X0 …… stage unspecified

H40.51X1 …… mild stage

H40.51X2 …… moderate stage

H40.51X3 …… severe stage

H40.51X4 …… indeterminate stage

H40.52 Glaucoma secondary to other eye disorders, left eye

H40.52X0 …… stage unspecified

H40.52X1 …… mild stage

H40.52X2 …… moderate stage

H40.52X3 …… severe stage

H40.52X4 …… indeterminate stage

H40.53 Glaucoma secondary to other eye disorders, bilateral

H40.53X0 …… stage unspecified

H40.53X1 …… mild stage

H40.53X2 …… moderate stage

H40.53X3 …… severe stage

H40.53X4 …… indeterminate stage

H40.6 Glaucoma secondary to drugs

H40.60 Glaucoma secondary to drugs, unspecified eye

H40.60X0 …… stage unspecified

H40.60X1 …… mild stage

H40.60X2 …… moderate stage

H40.60X3 …… severe stage

H40.60X4 …… indeterminate stage

H40.61 Glaucoma secondary to drugs, right eye

H40.61X0 …… stage unspecified

H40.61X1 …… mild stage

H40.61X2 …… moderate stage

H40.61X3 …… severe stage

H40.61X4 …… indeterminate stage

H40.62 Glaucoma secondary to drugs, left eye

H40.62X0 …… stage unspecified

H40.62X1 …… mild stage

H40.62X2 …… moderate stage

H40.62X3 …… severe stage

H40.62X4 …… indeterminate stage

H40.63 Glaucoma secondary to drugs, bilateral

H40.63X0 …… stage unspecified

H40.63X1 …… mild stage

H40.63X2 …… moderate stage

H40.63X3 …… severe stage

H40.63X4 …… indeterminate stage

H40.8 Other glaucoma

H40.81 Glaucoma with increased episcleral venous pressure

H40.811 …… right eye

H40.812 …… left eye

H40.813 …… bilateral

H40.819 …… unspecified eye

H40.82 Hypersecretion glaucoma

H40.821 …… right eye

H40.822 …… left eye

H40.823 …… bilateral

H40.829 …… unspecified eye

H40.83 Aqueous misdirection

H40.831 …… right eye

H40.832 …… left eye

H40.833 …… bilateral

H40.839 …… unspecified eye

H40.89 Other specified glaucoma

H40.9 Unspecified glaucoma

Please call us at 610-428-9034 or fill out our Contact Form.

In this post, we detail the 2024 Autism ICD 10 code – Diagnosis Code F84.9

Pervasive developmental disorder, unspecified

F84.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2024 edition of ICD-10-CM F84.9 became effective on October 1, 2023.

This is the American ICD-10-CM version of F84.9 – other international versions of ICD-10 F84.9 may differ.

Applicable To Atypical autism

The following code(s) above F84.9 contain annotation back-references that may be applicable to F84.9:

• F01-F99 Mental, Behavioral and Neurodevelopmental disorders
• F84 Pervasive developmental disorders

Approximate Synonyms

• Developmental disorder, pervasive
• Developmental disorder, pervasive, residual state
• Pervasive developmental disorder
• Pervasive developmental disorder of residual state

Clinical Information

• A category of developmental disorders characterized by impaired communication and socialization skills. The impairments are incongruent with the individual’s developmental level or mental age. These disorders can be associated with general medical or genetic conditions.
• Broad term for disorders, usually first diagnosed in children prior to age 4, characterized by severe and profound impairment in social interaction, communication, and the presence of stereotyped behaviors, interests, and activities. Compare developmental disabilities.
• Group of disorders characterized by delays in the development of socialization and communication skills; typical age of onset is before 3 years of age; symptoms may include problems with using and understanding language; difficulty relating to people, objects, and events; unusual play with toys and other objects; difficulty with changes in routine or familiar surroundings, and repetitive body movements or behavior patterns; autism is the most characteristic and best studied pdd; other types of pdd include asperger syndrome, childhood disintegrative disorder, and rett syndrome; prefer nts where possible.

ICD-10-CM F84.9 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

• 885 Psychoses

Convert F84.9 to ICD-9-CM

Code History

• 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
• 2017 (effective 10/1/2016): No change
• 2018 (effective 10/1/2017): No change
• 2019 (effective 10/1/2018): No change
• 2020 (effective 10/1/2019): No change
• 2021 (effective 10/1/2020): No change
• 2022 (effective 10/1/2021): No change
• 2023 (effective 10/1/2022): No change
• 2024 (effective 10/1/2023): No change

Code annotations containing back-references to F84.9:

Code Also: F78.A1

Diagnosis Index entries containing back-references to F84.9:

• Autism, autistic (childhood) (infantile) F84.0

atypical F84.9

• Delay, delayed development R62.50

Pervasive F84.9

• Disability, disabilities

intellectual F79

with

autistic features F84.9

• Disorder (of) – see also Disease

developmental F89

pervasive F84.9

pervasive, developmental F84.9

If you would like to learn more about Multiple Myeloma ICD 10 Codes, please call us at 610-428-9034 or fill out our Contact Form.

In this post we overview the ICD-10-CM Codes › C00-D49 › Malignant neoplasms of lip, oral cavity and pharynx C00-C14

Malignant neoplasms of lip, oral cavity and pharynx C00-C14

Codes

C00 – Malignant neoplasm of lip

C01 – Malignant neoplasm of base of tongue

C02 – Malignant neoplasm of other and unspecified parts of tongue

C03 – Malignant neoplasm of gum

C04 – Malignant neoplasm of floor of mouth

C05 – Malignant neoplasm of palate

C06 – Malignant neoplasm of other and unspecified parts of mouth

C07 – Malignant neoplasm of parotid gland

C08 – Malignant neoplasm of other and unspecified major salivary glands

C09 – Malignant neoplasm of tonsil

C10 – Malignant neoplasm of oropharynx

C11 – Malignant neoplasm of nasopharynx

C12 – Malignant neoplasm of pyriform sinus

C13 – Malignant neoplasm of hypopharynx

C14 – Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

Please call us at 610-428-9034 or fill out our Contact Form.